GO:0032925 | regulation of activin receptor signaling pathway | 1 | 4 |
GO:0030674 | protein binding, bridging | 1 | 37 |
GO:0005515 | protein binding | 198 | 4124 |
GO:0001776 | leukocyte homeostasis | 1 | 1 |
GO:0045892 | negative regulation of transcription, DNA-templated | 17 | 317 |
GO:0030097 | hemopoiesis | 3 | 48 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 18 | 161 |
GO:0005737 | cytoplasm | 127 | 2633 |
GO:0034968 | histone lysine methylation | 1 | 9 |
GO:0006974 | cellular response to DNA damage stimulus | 11 | 121 |
GO:0003682 | chromatin binding | 15 | 252 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2 | 45 |
GO:0000403 | Y-form DNA binding | 1 | 5 |
GO:0046621 | negative regulation of organ growth | 1 | 9 |
GO:0000400 | four-way junction DNA binding | 3 | 7 |
GO:0005829 | cytosol | 88 | 1787 |
GO:0045786 | negative regulation of cell cycle | 3 | 30 |
GO:0035097 | histone methyltransferase complex | 1 | 10 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1 | 20 |
GO:0045669 | positive regulation of osteoblast differentiation | 2 | 41 |
GO:0009411 | response to UV | 3 | 36 |
GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1 | 32 |
GO:0006351 | transcription, DNA-templated | 47 | 1076 |
GO:0010332 | response to gamma radiation | 2 | 26 |
GO:0003690 | double-stranded DNA binding | 6 | 83 |
GO:0060135 | maternal process involved in female pregnancy | 3 | 14 |
GO:0070412 | R-SMAD binding | 1 | 18 |
GO:0010467 | gene expression | 49 | 535 |
GO:0007050 | cell cycle arrest | 4 | 92 |
GO:0006338 | chromatin remodeling | 7 | 55 |
GO:0005730 | nucleolus | 74 | 1217 |
GO:0005654 | nucleoplasm | 68 | 876 |
GO:0047485 | protein N-terminus binding | 6 | 65 |
GO:0006281 | DNA repair | 24 | 203 |
GO:0008285 | negative regulation of cell proliferation | 11 | 277 |
GO:0051781 | positive regulation of cell division | 2 | 22 |
GO:0002051 | osteoblast fate commitment | 1 | 4 |
GO:0016363 | nuclear matrix | 10 | 73 |
GO:0000785 | chromatin | 6 | 59 |
GO:0000165 | MAPK cascade | 3 | 58 |
GO:0031062 | positive regulation of histone methylation | 1 | 3 |
GO:0048704 | embryonic skeletal system morphogenesis | 1 | 28 |
GO:0044212 | transcription regulatory region DNA binding | 13 | 143 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 5 | 107 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 29 | 644 |
GO:0045668 | negative regulation of osteoblast differentiation | 1 | 22 |
GO:0032092 | positive regulation of protein binding | 2 | 34 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 3 | 14 |
GO:0043234 | protein complex | 13 | 210 |
GO:0005634 | nucleus | 158 | 3246 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 29 | 456 |
GO:0043565 | sequence-specific DNA binding | 8 | 275 |
GO:0046329 | negative regulation of JNK cascade | 1 | 19 |
GO:0032154 | cleavage furrow | 3 | 30 |
GO:0007420 | brain development | 3 | 119 |
GO:0060021 | palate development | 1 | 47 |
GO:0001933 | negative regulation of protein phosphorylation | 3 | 30 |
GO:0002076 | osteoblast development | 1 | 15 |
GO:0018024 | histone-lysine N-methyltransferase activity | 1 | 15 |
GO:0051974 | negative regulation of telomerase activity | 1 | 5 |